Cargando…

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma

PURPOSE: Angiopoietin-like protein 2 (ANGPTL2) is a secretory glycoprotein with various functions in vascular biology, inflammation and tumor development. As shown in our previous studies, ANGPTL2 expression positively correlates with liver fibrosis stages in chronic hepatitis B (CHB) patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jiyuan, Yang, Wanna, Zhang, Shu, He, Xuanqiu, Lin, Jiatian, Zhou, Tao, Li, Yaqin, Wang, Guiqiang, Chen, Junhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681069/ https://www.ncbi.nlm.nih.gov/pubmed/31534368 http://dx.doi.org/10.2147/CMAR.S217170

Ejemplares similares

Angiopoietin-like protein as a novel marker for liver fibrosis in chronic hepatitis B patients with normal to minimally raised ALT
por: Deng, Yongqiong, et al.
Publicado: (2017)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma
por: Ng, Kevin Tak-Pan, et al.
Publicado: (2014)

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
por: Vanderborght, Bart, et al.
Publicado: (2020)

Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
por: Pestana, Roberto Carmagnani, et al.
Publicado: (2018)

Reappraisal of the diagnostic value of alpha‐fetoprotein for surveillance of HBV‐related hepatocellular carcinoma in the era of antiviral therapy
por: Qian, Xiangjun, et al.
Publicado: (2020)

Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis
por: Chen, Shilian, et al.
Publicado: (2018)

Gwen Douglas, MB ChB, FRCPsych
por: Shoenberg, Peter
Publicado: (2022)

Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma
por: Choi, Gwang Hyeon, et al.
Publicado: (2021)

Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8
por: Sylvers-Davie, Kelli L., et al.
Publicado: (2021)

The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis
por: Liu, Min, et al.
Publicado: (2023)

Diagnostic value of clusterin immunostaining in hepatocellular carcinoma
por: Li, Yuan, et al.
Publicado: (2020)

DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma
por: Zheng, Jing, et al.
Publicado: (2023)

Peter Sykes MB, ChB, FRCPsych, DPM
por: Savin, Emma
Publicado: (2018)

Angiopoietin-2 induces angiogenesis via exosomes in human hepatocellular carcinoma
por: Xie, Ji-yan, et al.
Publicado: (2020)

Angiopoietin-like protein 8 (betatrophin) may inhibit hepatocellular carcinoma through suppressing of the Wnt signaling pathway
por: Monzavi, Nastaran, et al.
Publicado: (2019)

Diagnostic and prognostic value of serum Chitinase 3‐like protein 1 in hepatocellular carcinoma
por: Wang, Shuwei, et al.
Publicado: (2022)

Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
por: Sun, Jin‐Yu, et al.
Publicado: (2020)

Angiopoietin-1, Angiopoietin-2 and Bicarbonate as Diagnostic Biomarkers in Children with Severe Sepsis
por: Wang, Kun, et al.
Publicado: (2014)

The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
por: Zhang, Zeyu, et al.
Publicado: (2019)

The bursal secretory dendritic cell (BSDC) and the enigmatic chB6(+) macrophage-like cell (Mal)
por: Oláh, Imre, et al.
Publicado: (2022)

Lynn Sinclair Gillis, MB ChB, MD, FRCPsych
por: Raphael-Leff, Joan
Publicado: (2021)

Abnormally primed CD8 T cells: The Achilles’ heel of CHB
por: Chen, Xiaoqing, et al.
Publicado: (2023)

Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
por: Bupathi, Manojkumar, et al.
Publicado: (2014)

Diagnostic and Prognostic Values of MANF Expression in Hepatocellular Carcinoma
por: He, Jingyi, et al.
Publicado: (2020)

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients
por: Chen, Xiaoman, et al.
Publicado: (2022)

Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease
por: Erkan, Gulbanu, et al.
Publicado: (2016)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
por: Wang, Jian-Yao, et al.
Publicado: (2021)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

The chitobiose transporter, chbC, is required for chitin utilization in Borrelia burgdorferi
por: Rhodes, Ryan G, et al.
Publicado: (2010)

Study on Post-Treatment Relapse in HBeAg Positive CHB Patients
por: Lu, Junfeng, et al.
Publicado: (2015)

Characteristics of the gut microbiota in professional martial arts athletes: A comparison between different competition levels
por: Liang, Ru, et al.
Publicado: (2019)

Tenacissoside H Induces Autophagy and Radiosensitivity of Hepatocellular Carcinoma Cells by PI3K/Akt/mTOR Signaling Pathway
por: Lin, Jiatian, et al.
Publicado: (2021)

Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB
por: Zhong, Yan-Wei, et al.
Publicado: (2011)

Distinct Clinical Impact and Biological Function of Angiopoietin and Angiopoietin-like Proteins in Human Breast Cancer
por: Yang, Hui, et al.
Publicado: (2021)

LINC02362 attenuates hepatocellular carcinoma progression through the miR-516b-5p/SOSC2 axis
por: Li, Dezhi, et al.
Publicado: (2022)

The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis
por: Jiang, Yao, et al.
Publicado: (2019)

Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Xu, Mingxing, et al.
Publicado: (2021)

Clinical significance of angiopoietin-like protein 4 expression in tissue and serum of esophageal squamous cell carcinoma patients
por: Yi, Jun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0m8q0cr4e4hs4m0cu8digi0ubo